Skip to main content

Table 1 Resistance rates to antimicrobials in E. faecalis isolates from urine and fecal specimens in patients with community acquired-UTIs

From: Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection

Antibiotics Urine samples
N = 63 (%)
Fecal samples
N = 63 (%)
R I S R I S
Ampicillin (10 µg) 0 (0%) 63 (100%) 0 (0%) 63 (100%)
Penicillin G (10 units) 0 (0%) 63 (100%) 0 (0%) 63 (100%)
Vancomycin (30 µg) 0 (0%) 63 (100%) 0 (0%) 63 (100%)
Linezolide (30 µg) 0 (0%) 63 (100%) 0 (0%) 63 (100%)
Nitrofurantoin (300 µg) 0 (0%) 63 (100%) 0 (0%) 63 (100%)
Gatifloxacin (5 µg) 8 (12.7%) 55 (87.3%) 4 (6.3%) 59 (93.7%)
Levofloxacin (5 µg) 9 (14.3%) 54 (85.7%) 4 (6.3%) 59 (93.7%)
Ciprofloxacin (5 µg) 13 (20.6%) 50 (79.4%) 8 (12.7%) 55 (87.3%)
Gentamycin (120 µg) 18 (28.6%) 45 (71.4%) 10 (15.9%) 53 (84.1%)
Minocycline (30 µg) 55 (87.3%) 8 (12.7%) 45 (71.4%) 18 (28.6%)
Tetracycline (30 µg) 56 (88.9%) 7 (11.1%) 48 (76.2%) 15 (23.8%)
Daptomycin 0 (0%) 63 (100%) 0 (0%) 63 (100%)
  1. Resistance phenotypes were determined for all antibiotics, except daptomycin, by disk diffusion (Kirby–Bauer) method according to CLSI 2014 guidelines (MastGroupLtd, United Kingdom). Resistance to daptomycinwas tested using E-tests trip (Liofilchem®, Italy)
  2. R resistant, I intermediary, S susceptible